期刊文献+

腹膜后淋巴结切除术在早期卵巢上皮性癌的临床应用价值分析 被引量:2

The Clinical Value of Retroperitoneal Lymphadenectomy for Early Stage Epithelial Ovarian Carcinoma
暂未订购
导出
摘要 目的探讨腹膜后淋巴结切除术在早期卵巢上皮性癌患者中的临床疗效及预后价值。方法回顾性分析2012年1月-2013年5月收治的68例早期卵巢上皮性癌患者临床资料,根据手术方案不同分为两组:研究组36例,行肿瘤细胞减灭术及腹膜后淋巴结切除术治疗;对照组32例,因各种原因未接受腹膜后淋巴结切除,仅行肿瘤细胞减灭术。比较两组患者手术相关指标;术后均随访1年,比较两组复发率、复发平均时间以及生存率。应用COX风险比例回归模型分析影响预后的临床因素。结果两组患者手术时间、术中出血量及住院时间比较均无显著差异(P〉0.05)。与对照组相比,研究组复发率较低,复发平均时间延长,1年生存率较高,差异具有统计学意义(P〈0.05)。临床分期、病理类型及腹膜后淋巴结切除对预后结局有显著影响(P〈0.05)。结论腹膜后淋巴结切除术对早期卵巢上皮性癌患者的临床疗效肯定,预后结局较好,应尽量在临床开展。 Objective To analyze the clinical effect and prognosis value of retroperitoneal lymphadenectomy on patients with early stage epithelial ovarian carcinoma. Methods The clinical data of 68 patients with early stage epithelial ovarian carcinoma were analyzed retrospective. According to surgical procedure, all cases were divided into two groups : research group with 36 cases were received cytoreductive surgery plus retroperitoneal lymphadenectomy, and control group with 32 cases were not received retroperitoneal lymphadenectomy because of all kinds causes. The operative indexes such as operative duration, intra-operative blood loss and hospital stays were compared between two groups. All cases were followed up for one year. The indexes of recurrence rate, mean recurrence duration and survival rate were compared between two groups. The independent prognostic factors were identified by the COX proportional hazards regression model. Results There was no statistical difference in surgical factors of operative duration, intra-operative blood loss and hospital stays between two groups (P 〉 0.05). Compared to control group, the index of the recurrence rate was lower ( P 〈 0.05 ), mean recurrence duration was longer ( P 〈 0.05 ) , and one-year survival rate was higher in research group ( P 〈 0. 05 ). The clinical stages, pathological types and retroperitoneal lymphadenectomy were confirmed to influence prognosis by the COX proportional hazards regression model. Conclusion The clinical and prognostic values of retroperitoneal lymphadenectomy is ideal and positive for early stage epithelial ovarian carcinoma, and it is worthy to be developing.
作者 汤岭梅
出处 《中国现代手术学杂志》 2014年第4期301-304,共4页 Chinese Journal of Modern Operative Surgery
关键词 卵巢肿瘤 淋巴结切除术 腹膜后 预后 ovarian neoplasms lymph node excision, retroperitoneal prognosis
  • 相关文献

参考文献8

  • 1马珂,温宏武,廖秦平.腹膜后淋巴结切除术在术中肉眼观察临床Ⅰ期卵巢上皮性癌中的意义[J].中国妇产科临床杂志,2010,11(2):105-108. 被引量:3
  • 2Maggioni A, Benedetti Panici P, Dell'Anna T, et al. Random- ised study of systematic lymphadenectomy in patients with epi- thelial ovarian cancer macroscopically confined to the pelvis [ J ]. Br J Cancer. 2006 Sep 18;95(6):699-704.
  • 3黄绮丹,黄鹤,刘继红.ⅢC期卵巢上皮性癌不同转移模式的临床分析[J].实用妇产科杂志,2013,29(12):921-924. 被引量:4
  • 4Kanat-Pektas M, Ozat M, Gungor T, et al. Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors? [J]. Arch Gynecol Obstet, 2011,283(4) :879- 884. doi: 10. 1007/s00404-010-1539-5.
  • 5余冬青,李力.腹膜后淋巴结清扫在卵巢上皮癌治疗中的作用[J].广东医学,2007,28(9):1489-1491. 被引量:4
  • 6Sakai K, Kajiyama H, Umezu T, et al. Is there any association between retroperitoncal lymphadenectomy and survival benefit in advanced stage epithelial ovarian carcinoma patients? [J]. J Ob- stet Gynaecol Res, 2012, 38 (7) : 1018-1023. doi : 10.1111/j. 1447-0756. 2011. 01826. x.
  • 7Abe A, Furumoto H, Irahara M, et al. The impact of systematic para-aortic and pelvic lymphadencctomy on survival in patients with optimally debulked ovarian cancer [ J ]. J Obstet Gynaecol Res, 2010, 36(5):1023-1030.
  • 8Classe JM, Cerato E, Boursier C, et al. Retroperitoneal lymph- adenectomy and survival of patients treated for an advanced ovari- an cancer: the CARACO trial[ J]. J Gynecol Obstet Biol Reprod (Paris) , 2011, 40(3) :201-4. doi: 10. 1016/j. jgyn. 2011. 02. 009.

二级参考文献28

  • 1Wu PC, Lang JH, Huang RL, et al. Lymph Node Metastasis and Retroperitoneal Lymphadenectomy in Ovirian Cancer. Bailliere's Clinical Obstetrics and Gynecology, 1989, 3: 143 - 155.
  • 2Scarabell IC, Gallo A, Zarrell IA, et al. Systematic pelvic and para - aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol, 1995, 56: 328-337.
  • 3Benedetti PP, Maggion IA, Hacker N, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes in optimally debulked advanced ovarian cancer: a randomized clinical trial. J National Cancer Inst, 2005, 97: 560 - 566.
  • 4Chid S, Eisenhauer EL, Lang J, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage Ⅲ C epithelial ovarian carcinoma (EOC). Gynecol Oncoh 2006, 103: 559-564.
  • 5Chan JK, Munro EG, Cheungm K. Association of lymphade- nectomy and survival in stage Ⅰ ovarian cancer patients. Obstet Gynecol, 2007, 109:12-19.
  • 6Maggioni A, Benedetti PP, Anna TD, et al. Randomized study of systematic lymphadeneetomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer, 2006, 95: 699-704.
  • 7Cho YH, Kim DY, Kim JH, et al. Is complete surgical necessary in patients with stage Ⅰ mutinous epithelial ovarian tumors. Gynecol Oncol, 2006, 103.- 878-882.
  • 8Trope C, Kaern J. Adjuvant chemotherapy for early stage ovarian cancer: review of the literature. J Clin Oneol, 2007, 25: 2909- 2920.
  • 9连丽娟,林巧稚.妇科肿瘤学[M].4版.北京:人民卫生出版社,2006:514-516.
  • 10DI TE F,BAIOCCHI G.Value of lymph node assessment in ovarian cancer:Status of the art at the end of the second millennium[J].Int J gynecol Cancer,2000,10(6):435 -442

共引文献8

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部